On November 3, INNOSCIENCE fell 5.02% in regular trading, with shares trading at HK$25.3 and turnover reaching HK$78.75 million.
The latest disclosed catalyst is the company’s November 2 announcement that it granted 3,273,300 H shares to 154 employees under its 2025 share award scheme, a development that may keep investor focus on potential dilution, while semiconductor names broadly traded lower.
Background details show the scheme’s total mandate covers 49,125,718 H shares, equivalent to 10% of issued H shares at adoption. Before this grant, the trustee had already purchased 4,822,100 H shares and had not made any grant. After the award, 45,852,418 H shares remain available for future grants. Earlier, from July 8 to October 16, the trustee bought 2,251,100 H shares in the market for about HK$101 million at an average price of roughly HK$45.02 per share.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments